Zeitschrift für Gastroenterologie

LinksSchließen

Referenz

Souglakos J et al.
FOLFOXIRI (folinic acid, 5-fluorouracil, oxaliplatin and irinotecan) vs. FOLFIRI (folinic acid, 5-fluorouracil and irinotecan) as first-line treatment in metastatic colorectal cancer (MCC): a multicentre randomised phase III trial from the Hellenic Oncology Research Group (HORG).

Br J Cancer 2006;
94 (06) 798-805

Bibliographische Angaben herunterladen

Suchen in:

Aufrufen in: